ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Apr 19, 2008 ELITE PHARMACEUTICALS APPOINTS CHIEF SCIENTIFIC OFFICER

Mar 31, 2008 Elite Pharmaceuticals, Inc. Reports Opioid Abuse-Resistant Products Gaining Momentum

Mar 03, 2008 Elite Pharmaceuticals, Inc. to Present at the Susquehanna Financial Healthcare Conference

Feb 14, 2008 Elite Pharmaceuticals, Inc. to Present Clinical Data at the American Academy of Pain Medicine's 24th Annual Meeting

Jan 23, 2008 Elite Pharmaceuticals, Inc. Retains The Global Consulting Group as Strategic Communications Advisors

Jan 08, 2008 Elite Pharmaceuticals Appoints Stuart Apfel, M.D. as Chief Medical Officer

Nov 28, 2007 Elite Pharmaceuticals, Inc. to Present at BMO Capital Markets Focus on Healthcare Conference

Nov 09, 2007 Elite Pharmaceuticals, Inc. Concludes a Special Protocol Assessment with the FDA on a Pivotal Phase 3 Study on Elite's Abuse Deterrent Oxycodone Product

Nov 01, 2007 Elite Pharmaceuticals to Present at Acumen BioFin 9th Annual Healthcare Conference

Jul 17, 2007 ELITE ANNOUNCES CLOSING OF SERIES C PRIVATE PLACEMENT

20 21 22 23 24 25 26 27 28 29 30

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand